These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3465171)

  • 41. Longitudinal study of the pubertal growth spurt in children born small for gestational age without postnatal catch-up growth.
    Vicens-Calvet E; Espadero RM; Carrascosa A;
    J Pediatr Endocrinol Metab; 2002 Apr; 15(4):381-8. PubMed ID: 12008684
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Compensatory maturational deceleration of growth or "catch-down growth" in patients with congenital adrenal hyperplasia after delayed initiation of therapy.
    Hunziker U; Largo R; Zachmann M; Prader A
    Eur J Pediatr; 1986 Apr; 144(6):550-3. PubMed ID: 3486767
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Puberty and adult height in congenital virilizing adrenal hyperplasia (author's transl)].
    Himon F; Job JC; Pierson M; Canlorbe P
    Ann Pediatr (Paris); 1981 Mar; 28(3):187-92. PubMed ID: 7224567
    [No Abstract]   [Full Text] [Related]  

  • 44. In boys with abnormal developmental tempo, maturation of the skeleton and the hypothalamic-pituitary-gonadal axis remains synchronous.
    Flor-Cisneros A; Leschek EW; Merke DP; Barnes KM; Coco M; Cutler GB; Baron J
    J Clin Endocrinol Metab; 2004 Jan; 89(1):236-41. PubMed ID: 14715856
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CYP21 genotype, adult height, and pubertal development in 55 patients treated for 21-hydroxylase deficiency.
    Balsamo A; Cicognani A; Baldazzi L; Barbaro M; Baronio F; Gennari M; Bal M; Cassio A; Kontaxaki K; Cacciari E
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5680-8. PubMed ID: 14671153
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Growth inhibition by glucocorticoid treatment in salt wasting 21-hydroxylase deficiency: in early infancy and (pre)puberty.
    Stikkelbroeck NM; Van't Hof-Grootenboer BA; Hermus AR; Otten BJ; Van't Hof MA
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3525-30. PubMed ID: 12915631
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Muscle strength in girls with congenital adrenal hyperplasia.
    Rodda C; Jones DA; Round J; Grant DB
    Acta Paediatr Scand; 1987 May; 76(3):495-9. PubMed ID: 3604667
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Growth and body proportions in congenital adrenal hyperplasia.
    Young MC; Ribeiro J; Hughes IA
    Arch Dis Child; 1989 Nov; 64(11):1554-8. PubMed ID: 2604414
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Growth and puberal development in males with adreno-genital syndrome].
    Gargantini L; Calzi P; Brunelli V; Braggion F; Chiumello G
    Pediatr Med Chir; 1989; 11(6):597-602. PubMed ID: 2699925
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of therapy on mature height in congenital adrenal hyperplasia.
    Kirkland RT; Keenan BS; Holcombe JH; Kirkland JL; Clayton GW
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1320-4. PubMed ID: 263352
    [No Abstract]   [Full Text] [Related]  

  • 51. Birth Size in Neonates with Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency.
    Dörr HG; Penger T; Albrecht A; Marx M; Völkl TMK
    J Clin Res Pediatr Endocrinol; 2019 Feb; 11(1):41-45. PubMed ID: 30178749
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adrenarche and puberty in children with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Völkl TM; Öhl L; Rauh M; Schöfl C; Dörr HG
    Horm Res Paediatr; 2011; 76(6):400-10. PubMed ID: 22123283
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Blood pressure in children and adolescents with congenital adrenal hyperplasia (21-hydroxylase deficiency): a preliminary report.
    Roche EF; Charmandari E; Dattani MT; Hindmarsh PC
    Clin Endocrinol (Oxf); 2003 May; 58(5):589-96. PubMed ID: 12699440
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Growth of children with physiolysis of the hip.
    Hägglund G; Hansson LI; Hansson V; Karlberg J
    Acta Orthop Scand; 1987 Apr; 58(2):117-20. PubMed ID: 3604623
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bone mineral density in prepubertal and in adolescent and young adult patients with the salt-wasting form of congenital adrenal hyperplasia.
    Gussinyé M; Carrascosa A; Potau N; Enrubia M; Vicens-Calvet E; Ibáñez L; Yeste D
    Pediatrics; 1997 Oct; 100(4):671-4. PubMed ID: 9310523
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [State of the renin-angiotensin system in children with different clinical variants of congenital adrenal cortex hyperplasia caused by 21-hydroxylase deficiency].
    Kasatkina EP; Tiul'pakov AN; Goriaĭnova II
    Pediatriia; 1992; (2):35-40. PubMed ID: 1513631
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Congenital hyperplasia of the adrenal glands. Case reports].
    Colabucci F; Marietti G
    Minerva Pediatr; 1976 Jun; 28(22):1406-17. PubMed ID: 948343
    [No Abstract]   [Full Text] [Related]  

  • 58. Near-final height in 82 Chinese patients with congenital adrenal hyperplasia due to classic 21-hydroxylase deficiency: a single-center study from China.
    Juan L; Huamei M; Zhe S; Yanhong L; Hongshan C; Qiuli C; Jun Z; Song G; Minlian D
    J Pediatr Endocrinol Metab; 2016 Jul; 29(7):841-8. PubMed ID: 27054598
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Growth of very low birth weight infants to age 20 years.
    Hack M; Schluchter M; Cartar L; Rahman M; Cuttler L; Borawski E
    Pediatrics; 2003 Jul; 112(1 Pt 1):e30-8. PubMed ID: 12837903
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Persistent obesity and short final height after corticoid overtreatment for congenital adrenal hyperplasia (CAH) in infancy.
    Knorr D; Hinrichsen de Lienau SG
    Acta Paediatr Jpn; 1988; 30 Suppl():89-92. PubMed ID: 3146883
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.